Trial
NCT02578121
UARK 2015-03 A Phase II Trial of a Novel Proteasome/IMiD Combination
Phase IIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
University of Arkansas
Collaborators
—
Condition
Multiple Myeloma
Intervention
Ixazomib
Why stopped
Investigator decided to close study without enrollment
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-01-23